CONMED Past Earnings Performance

Past criteria checks 4/6

CONMED has been growing earnings at an average annual rate of 16.8%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 7.9% per year. CONMED's return on equity is 14.1%, and it has net margins of 10.2%.

Key information

16.8%

Earnings growth rate

15.3%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate7.9%
Return on equity14.1%
Net Margin10.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How CONMED makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:EC8 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,28813251655
30 Jun 241,2769951154
31 Mar 241,2628250954
31 Dec 231,2456450553
30 Sep 231,1695848351
30 Jun 231,1398847951
31 Mar 231,099-9446249
31 Dec 221,045-8143947
30 Sep 221,069-8344046
30 Jun 221,042-11442744
31 Mar 221,0206842044
31 Dec 211,0116341544
30 Sep 219896240544
30 Jun 219795439343
31 Mar 218811336940
31 Dec 208621037440
30 Sep 20874036941
30 Jun 20870037342
31 Mar 209513439145
31 Dec 199552938845
30 Sep 199332938344
30 Jun 199012837043
31 Mar 198763136141
31 Dec 188604135338
30 Sep 188407234936
30 Jun 188287334534
31 Mar 188127133732
31 Dec 177965533132
30 Sep 177781532332
30 Jun 177731631832
31 Mar 177691231732
31 Dec 167641531332
30 Sep 167501630631
30 Jun 167351730230
31 Mar 167222229229
31 Dec 157193028727
30 Sep 157233428728
30 Jun 157292729128
31 Mar 157363029627
31 Dec 147403230328
30 Sep 147473131027
30 Jun 147503530827
31 Mar 147533430927
31 Dec 137633631826

Quality Earnings: EC8 has a large one-off gain of $48.7M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: EC8's current net profit margins (10.2%) are higher than last year (5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EC8's earnings have grown by 16.8% per year over the past 5 years.

Accelerating Growth: EC8's earnings growth over the past year (127.2%) exceeds its 5-year average (16.8% per year).

Earnings vs Industry: EC8 earnings growth over the past year (127.2%) exceeded the Medical Equipment industry 10.1%.


Return on Equity

High ROE: EC8's Return on Equity (14.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 21:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CONMED Corporation is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Travis SteedBarclays
Travis SteedBofA Global Research
Kristen StewartCL King & Associates, Inc.